Cite Filings / NRIX / 0000102909-26-002007

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Nurix Therapeutics, Inc. Filed 2026-03-27 Acc 0000102909-26-002007

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-04-24 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-04-02 4 Chief Legal Officer sold 8,148 shares at $15.24 ($124,149)
2026-03-27 ARS Annual Report to Security Holders
2026-03-27 DEFA14A Proxy Materials
2026-03-27 DEF 14A Proxy Statement
2026-03-27 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…